Inhibitor Therapeutics (INTI) Share-based Compensation (2013 - 2025)
Inhibitor Therapeutics' Share-based Compensation came in at $23,385 for FY2025, down 41.9% from $40,250 in FY2024.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Share-based Compensation (2013 - 2025) Analysis & Trends
Going back to FY2014, Inhibitor Therapeutics' Share-based Compensation data covers 11 years.
- Share-based Compensation carries a five-year compound annual growth rate of -36.6% (FY2020 to FY2025).
- The five-year range for annual Share-based Compensation is $13,784 (FY2023) to $40,250 (FY2024).
- Per Business Quant, earlier years put Share-based Compensation at $40,250 in FY2024 (+192.0%), $13,784 in FY2023 and $37,990 in FY2021 (-83.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Inhibitor Therapeutics | 19.12 Mn | 11.93 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 8,385.00 |
| Jun 30, 2024 | 1,160.00 |
| Mar 31, 2024 | 18,090.00 |
| Sep 30, 2023 | 1,534.00 |
| Mar 31, 2021 | 37,990.00 |
| Dec 31, 2020 | 119,336.00 |
| Sep 30, 2020 | 49,953.00 |
| Jun 30, 2020 | 42,753.00 |
| Mar 31, 2020 | 16,819.00 |
| Dec 31, 2019 | 30,162.00 |
| Sep 30, 2019 | 27,117.00 |
| Jun 30, 2019 | 81,614.00 |
| Mar 31, 2019 | 131,031.00 |
| Dec 31, 2018 | 125,451.00 |
| Sep 30, 2018 | 125,451.00 |
| Jun 30, 2018 | 83,953.00 |
| Mar 31, 2018 | 208,243.00 |
| Dec 31, 2017 | 14,060.00 |
| Sep 30, 2017 | 14,064.00 |
| Jun 30, 2017 | 9,376.00 |
API Access
Inhibitor Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();